All Stories

  1. Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP
  2. The Sherpa hypothesis: Phenotype-Preserving Disordered Proteins stabilize the phenotypes of neurons and oligodendrocytes
  3. Pharmacological targeting of α‐synuclein and TPPP /p25 in Parkinson's disease: challenges and opportunities in a Nutshell
  4. Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals)
  5. Role of the microtubule-associated TPPP/p25 in Parkinson’s and related diseases and its therapeutic potential
  6. Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins
  7. Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure–Activity Relationship Study
  8. Strukturbasierte Entwicklung einer Affinitätssonde für Sirtuin 2
  9. Targeting the interface of the pathological complex of α-synuclein and TPPP/p25
  10. Accumulation of the PX domain mutant Frank-ter Haar syndrome protein Tks4 in aggresomes
  11. Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
  12. Modeling of sensing potency of cytoskeletal systems decorated with metabolic enzymes
  13. Zinc-induced structural changes of the disordered tppp/p25 inhibits its degradation by the proteasome
  14. Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors
  15. Dual life of TPPP/p25 evolved in physiological and pathological conditions
  16. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25
  17. Sensor potency of the moonlighting enzyme-decorated cytoskeleton: the cytoskeleton as a metabolic sensor
  18. Microtubule assembly-derived by dimerization of TPPP/p25. Evaluation of thermodynamic parameters for multiple equilibrium system from ITC data
  19. Zn2+-Induced Rearrangement of the Disordered TPPP/p25 Affects Its Microtubule Assembly and GTPase Activity
  20. Moonlighting proteins in neurological disorders
  21. A new myelin protein, TPPP/p25, reduced in demyelinated lesions is enriched in cerebrospinal fluid of multiple sclerosis
  22. Proteins without 3D structure: definition, detection and beyond
  23. Disordered TPPP/p25 binds GTP and displays Mg2+-dependent GTPase activity
  24. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis
  25. Reappraisal of triosephosphate isomerase deficiency
  26. Triosephosphate isomerase deficiency: New insights into an enigmatic disease
  27. Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation
  28. An unstructured protein with destructive potential: TPPP/p25 in neurodegeneration
  29. Unique pharmacology of KAR-2, a potential anti-cancer agent: Absorption modelling and selective mitotic spindle targeting
  30. ChemInform Abstract: Conformationally Constrained Adamantaneoxazolines of Pharmacological Interest.
  31. TPPP orthologs are ciliary proteins
  32. The tubulin polymerization promoting protein, TPPP/p25
  33. Increased glucose metabolism and ATP level in brain tissue of Huntington’s disease transgenic mice
  34. Triosephosphate isomerase deficiency: Facts and doubts
  35. TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells
  36. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases
  37. Tubulin Polymerization Promoting Proteins (TPPPs):  Members of a New Family with Distinct Structures and Functions†
  38. Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies
  39. Spotlight on…Judit Ovádi
  40. Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels
  41. Structure of Calmodulin in complex with KAR-2, a bis-indol alkaloid
  42. Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies
  43. Functional aspects of cellular microcompartmentation in the development of neurodegeneration: Mutation induced aberrant protein-protein associations
  44. Glucose conversion by multiple pathways in brain extract: theoretical and experimental analysis
  45. A simple method for the determination of dissociation constants by displacement ELISA
  46. Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease
  47. Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease
  48. Dedications to Paul Srere
  49. Phosphofructokinases
  50. Tubulin and microtubule are potential targets for brain hexokinase binding
  51. Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease
  52. Organization-dependent effects of toxic bivalent ions
  53. Quantitative characterization of homo- and heteroassociations of muscle phosphofructokinase with aldolase
  54. Implications of Cytoarchitectural Analysis
  55. Substrate Channeling
  56. Paul A. Srere (1925–1999)
  57. Combined Enhancement of Microtubule Assembly and Glucose Metabolism in Neuronal Systems in Vitro: Decreased Sensitivity to Copper Toxicity
  58. Application of metabolic control analysis to the study of toxic effects of copper in muscle glycolysis
  59. Phosphofructokinase from Dictyostelium discoideum Is a Potent Inhibitor of Tubulin Polymerization †
  60. Macromolecular Compartmentation and Channeling
  61. Pyruvate Kinase as a Microtubule Destabilizing Factorin Vitro
  62. CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:2 COMPLEX)
  63. Comparison of control analysis data using different approaches: modelling and experiments with muscle extract
  64. Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity
  65. Crystallization and preliminary diffraction analysis of Ca2+-calmodulin-drug and apocalmodulin-drug complexes
  66. Characterization of Microtubule−Phosphofructokinase Complex:  Specific Effects of MgATP and Vinblastine †
  67. Metabolic Consequences of Enzyme Interactions
  68. Metabolic consequences of enzyme interactions
  69. Specific characteristics of phosphofructokinase-microtubule interaction
  70. Anti-calmodulin potency of indol alkaloids in in vitro systems
  71. Binding of malate dehydrogenase and NADH channelling to complex I
  72. Channel your energies
  73. Calmodulin and Dynamics of Interactions of Cytosolic Enzymes
  74. Quantitative evaluation of indirect ELISA effect of calmodulin antagonists on antibody binding to calmodulin
  75. Modulation of the interaction between aldolase and glycerol-phosphate dehydrogenase by fructose phosphates
  76. Calmodulin is a potent target for new hypothalamic neuropeptides
  77. Enzyme-enzyme interactions and their metabolic role
  78. Structurally distinct mammalian calmodulins
  79. Cooperative effect of fructose bisphosphate and glyceraldehyde-3-phosphate dehydrogenase on aldolase action
  80. Tamás Keleti (1927–1989)
  81. Channelling and Channel Efficiency: Theory and Analytical Implications
  82. Effects of drugs on calmodulin-mediated enzymatic actions
  83. Kinetic and physico-chemical analysis of enzyme complexes and their possible role in the control of metabolism
  84. Old pathway — new concept: control of glycolysis by metabolite- modulated dynamic enzyme associations
  85. Modulation of phosphofructokinase action by macromolecular interactions. Quantitative analysis of the phosphofructokinase-aldolase-calmodulin system
  86. Control of Metabolism by Dynamic Macromolecular Interactions
  87. Aldolase decreases the dissociation-induced inactivation of muscle phosphofructokinase
  88. A simple approach to identify the mechanism of intermediate transfer: enzyme system related to triose phosphate metabolism
  89. A simple approach to detect active-site-directed enzyme-enzyme interactions. The aldolase/glycerol-phosphate-dehydrogenase enzyme system
  90. How to determine the efficiency of intermediate transfer in an interacting enzyme system?
  91. Quantitative determination of triosephosphates during enzymatic reaction by high performance liquid chromatography: effect of isomerase on aldolase activity
  92. Dynamic interactions of enzymes involved in triosephosphate metabolism
  93. Isolation and quantitative determination of some cardioactive glycosides from Digitalis lanata by high-performance liquid chromatography
  94. Phosphofructokinase and fructosebisphosphatase from muscle can interact at physiological concentrations with mutual effects on their kinetic behavior
  95. Interaction of the Dissociable Glycerol-3-phosphate Dehydrogenase and Fructose-1,6-bisphosphate Aldolase. Quantitative Analysis by an Extrinsic Fluorescence Probe
  96. Interaction between D-Fructose-1,6-bisphosphate aldolase and triosephosphate isomerase
  97. Kinetics of Coupled Reactions Catalyzed by Aspartate Aminotransferase and Glutamate Dehydrogenase
  98. Physico-chemical Evidence for the Interaction between Aldolase and Glyceraldehyde-3-phosphate Dehydrogenase
  99. SH groups masked by subunit interaction in glyceraldehyde-3-phosphate dehydrogenase
  100. TPPP/p25: A New Unstructured Protein Hallmarking Synucleinopathies